US approval for Lyumjev

The FDA has approved Lilly’s Lyumjev rapid-acting mealtime insulin to reduce high blood sugar after meals and keep blood glucose levels in-range. This approval offers

Read More »

Semaglutide for T2s

The European Medicines Agency’s human medicines committee (CHMP) has recommended granting a marketing authorization in the EU for Rybelsus (semaglutide) for the treatment of adults

Read More »

ADA endorses US diabetes bills

The American Diabetes Association (ADA) announced the formal endorsement of three bills aiming to reduce the high cost of insulin and prescription drugs.  The Insulin Price

Read More »

Pre-bolusing is back

In a report entitled, Optimal prandial timing of bolus insulin in diabetes management: a review, looked at data from several studies and concluded that taking

Read More »